1. Drugs to Alter Extracellular Concentration of Glutamate: Modulators of Glutamate Uptake Systems
   Andréia Cristina Karklin Fontana, 2018, Biochemical Approaches for Glutamatergic Neurotransmission CrossRef
2. Desferrioxamine and dextromethorphan combination exhibited synergistic effect and reversed the catalepsy behaviour in 6-hydroxydopamine hydroydopamine administered rats through regulating brain glutamate levels†
   Navaf Mannan Thodukayil et al, 2019, Journal of Pharmacy and Pharmacology CrossRef
3. The Time Sequence of Gene Expression Changes after Spinal Cord Injury
   Seyoung Mun et al, 2022, Cells CrossRef
4. Dextromethorphan: An update on its utility for neurological and neuropsychiatric disorders
   Linda Nguyen et al, 2016, Pharmacology & Therapeutics CrossRef
5. Severity of experimental traumatic brain injury modulates changes in concentrations of cerebral free amino acids
   Angela Maria Amorini et al, 2017, Journal of Cellular and Molecular Medicine CrossRef
6. Late Effects
   Jeff Victoroff, 2019, Concussion and Traumatic Encephalopathy CrossRef
7. Glutamatergic neurotransmission: A potential pharmacotherapeutic target for the treatment of cognitive disorders
   Pratik Chakraborty et al, 2023, Ageing Research Reviews CrossRef
8. The N-Methyl-D-Aspartate Receptor Antagonist Dextromethorphan Improves Glucose Homeostasis and Preserves Pancreatic Islets in NOD Mice
   Laura Wörmeyer et al, 2024, Hormone and Metabolic Research CrossRef
9. Restoration of Sarco/Endoplasmic Reticulum Ca2+-ATPase Activity Functions as a Pivotal Therapeutic Target of Anti-Glutamate-Induced Excitotoxicity to Attenuate Endoplasmic Reticulum Ca2+ Depletion
   Wen Zhang et al, 2022, Frontiers in Pharmacology CrossRef
10. The effect of dextromethorphan use in Parkinson's disease: A 6-hydroxydopamine rat model and population-based study
    Cheng-Tsung Liu et al, 2019, European Journal of Pharmacology CrossRef
11. Oral Dextromethorphan for the Treatment of Diabetic Macular Edema: Results From a Phase I/II Clinical Study
    David J. Valent et al, 2018, Translational Vision Science & Technology CrossRef
12. Mechanisms of manganese-induced neurotoxicity and the pursuit of neurotherapeutic strategies
    Edward Pajarillo et al, 2022, Frontiers in Pharmacology CrossRef
13. Etifoxine improves sensorimotor deficits and reduces glial activation, neuronal degeneration, and neuroinflammation in a rat model of traumatic brain injury
    Emmanuelle Simon-O’Brien et al, 2016, Journal of Neuroinflammation CrossRef
14. Dextromethorphan Suppresses Lipopolysaccharide-Induced Epigenetic Histone Regulation in the Tumor Necrosis Factor-α Expression in Primary Rat Microglia
    Yung-Ning Yang et al, 2020, Mediators of Inflammation CrossRef
15. Naringin provides neuroprotection in CCL2-induced cognition impairment by attenuating neuronal apoptosis in the hippocampus
    Jiang-yi Long et al, 2020, Behavioral and Brain Functions CrossRef
16. A review on neurodevelopmental abnormalities in congenital heart disease: focus on minimizing the deleterious effects on patients
    Bai-hong Zheng et al, 2021, All Life CrossRef
17. The use of ketamine as a neuroprotective agent following cardiac arrest: A scoping review of current literature
    Marlena Ornowska et al, 2023, CNS Neuroscience & Therapeutics CrossRef